DIAGNOPTICS

diagnoptics-logo

Diagnoptics is the pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications. Its technological advance in detecting fluorescence of Advanced Glycation Endproducts (AGEs) has led to the invention of the AGE Readerโ„ข - a state of art diagnostic device which can determine the tissue accumulation of AGEs in 30 seconds.

#People #Website #More

DIAGNOPTICS

Social Links:

Industry:
Health Care Health Diagnostics Medical Device

Founded:
2003-01-01

Address:
Groningen, Groningen, The Netherlands

Country:
The Netherlands

Website Url:
http://www.diagnoptics.com

Total Employee:
11+

Status:
Active

Contact:
+31 50 589 0612

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network Google Universal Analytics



Current Advisors List

not_available_image

Ir. Reindert Graaff Technical Advisor/Founder @ Diagnoptics
Advisor

not_available_image

Andries J. Smit Medical Advisor/Founder @ Diagnoptics
Advisor

Current Employees Featured

tom-eestermans_image

Tom Eestermans
Tom Eestermans Mobile Application Developer @ Diagnoptics
Mobile Application Developer

bart-van-den-berg_image

Bart Van den Berg
Bart Van den Berg CEO @ Diagnoptics
CEO

Founder


not_available_image

Andries J. Smit

not_available_image

Ir. Reindert Graaff

Official Site Inspections

http://www.diagnoptics.com Semrush global rank: 8.57 M Semrush visits lastest month: 286

  • Host name: d-onit1.host-ed.eu
  • IP address: 85.10.149.31
  • Location: France
  • Latitude: 48.8582
  • Longitude: 2.3387
  • Timezone: Europe/Paris

Loading ...

More informations about "Diagnoptics"

Diagnoptics - Crunchbase Company Profile & Funding

Diagnoptics is the pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its โ€ฆSee details»

Diagnoptics - AGE Scanner

About the organization. Diagnoptics, founded in 2003, is a pioneer in advanced diagnostic devices used by medical professionals to non-invasively assess the risk to develop chronic illnesses โ€ฆSee details»

Management - Diagnoptics

John Mulder (MBA) CEO Mr. Mulder, who holds an MBA from Groningen University in The Netherlands, joined Diagnoptics in August 2023. With a rich โ€ฆSee details»

Diagnoptics 2025 Company Profile: Valuation, Funding โ€ฆ

Diagnoptics General Information Description. Developer of non-invasive diagnostic equipment designed to assess cardiovascular risk and the risk of โ€ฆSee details»

Diagnoptics. Niet-invasieve inschatting van het cardiovasculair โ€ฆ

Neem contact op met Diagnoptics of de distributeur in uw land voor informatie over de wettelijke goedkeuring in uw land. Waarschuwing voor de VS: Het systeem met de AGE reader en Diab โ€ฆSee details»

Diagnoptics - LinkedIn

Diagnoptics | 489 followers on LinkedIn. Established in 2003, Diagnoptics is the pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of ...See details»

Diagnoptics - Contacts, Employees, Board Members, Advisors

Diagnoptics is the pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes. ... Log In. Log In. Experience the new Crunchbase, โ€ฆSee details»

Diagnoptics - Products, Competitors, Financials, Employees ...

Diagnoptics specializes in non-invasive diagnostic devices for assessing cardiovascular risk and the risk of diabetes within the healthcare technology sector. The company's main product, the โ€ฆSee details»

DiagnOptics Company Profile - Office Locations, Competitors

DiagnOptics Summary. Company Summary. Overview. DiagnOptics is a company that develops cutting-edge diagnostic devices. It offers cardiovascular risk systems, advanced glycation โ€ฆSee details»

Diagnoptics - Overview, News & Similar companies - ZoomInfo

Mar 19, 2021 Diagnoptics has received a Todokede registration from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for the AGE Reader mu in Japan. This โ€ฆSee details»

Diagnoptics - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Diagnoptics is the pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes. Search Crunchbase. Start Free Trial . Chrome โ€ฆSee details»

Diagnoptics - Company Profile - Tracxn

Feb 22, 2025 Diagnoptics - Non-invasive device to assess cardiovascular and diabetes risk. Raised funding from 2 investors. Diagnoptics has 48 competitors.See details»

AGE Scanner

The AGE Scanner from Diagnoptics: insight into your AGE levels in no time. AGEs are fluorescent. This means that, if you shine an imperceptible amount of UV light on them, they โ€ฆSee details»

Diagnoptics - Crunchbase

Diagnoptics specializes in non-invasive diabetes risk assessment, while Hutman Diagnostics and Augurix focus on in vitro diagnostics for various diseases. HorizON Business HUB's DAT โ€ฆSee details»

Diagnoptics CEO, Founder, Key Executive Team, Board of Directors ...

Explore {Diagnoptics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

Diagnoptics news

Jul 22, 2021 New Leadership at Diagnoptics: John Mulder Takes Helm as CEO Weโ€™re thrilled to announce a significant leadership change at Diagnoptics as John Mulder becomes our new โ€ฆSee details»

Diagnomics Lab

Diagnomics Lab. is a trusted provider of innovative genetic testing platforms for both organizations and individual consumers. We strive to deliver confidence and reliability by offering โ€ฆSee details»

The company - diagnoptics.com

Diagnoptics Technologies B.V. Aarhusweg 4-9 9723 JJ Groningen The Netherlands Tel: +31 (0)50 589 0612 Fax: +31 (0)50 589 0613 E-mail: [email protected] Follow us on Twitter โ€ฆSee details»

Theranostics could save lives if industry leaders work together ...

1 day ago The World Health Organization has made a disturbing global prediction, estimating that 35 million new cancer cases are expected by 2050 โ€” an increase of 77% from 2022, โ€ฆSee details»

Download 300x52 - diagnoptics.com

24 August 2023 New Leadership at Diagnoptics: John Mulder Takes Helm as CEO . 7 November 2022 Support activities for all AGE Reader SU models to end soon . 7 October 2021 AGE โ€ฆSee details»